GHK-Cu collagen evidence: what the topical study actually showed
GHK-Cu is one of the few peptides with human data. The most-cited study is real, but it is small, topical and older than most summaries suggest.
Almost every peptide in this space has no human data. GHK-Cu has some, but the evidence is narrower than the way it is usually summarized.
The most-cited study
The most-cited study is a 12-week topical comparison on thigh skin. Collagen production rose in 70% of the GHK-Cu cream group, compared with 50% of the vitamin C cream group and 40% of the retinoic acid group. That is a real signal.
The fine print
- The study was topical, on skin, not systemic.
- The cohort was small, the study dates from the 1990s, and much of the follow-up literature traces back to one research group.
- GHK-Cu is a charged molecule that penetrates intact skin poorly without delivery help, which is why so much newer work focuses on formulation.
Signaling, not irritation
Retinoids drive turnover through controlled irritation. GHK-Cu is studied as a signaling molecule, linked to collagen I, collagen III and elastin gene expression without that irritation cascade. The downstream interest is the same, but the upstream route is different.
An accurate summary
Promising, early and limited by delivery. On current evidence, GHK-Cu is not a retinol killer.
Reviews referenced: Pickart and Margolina, 2018 (PMID 29986520), and Pickart et al., 2015 (PMID 26236730).